|

AUCD Community Inclusion

AUCD’s Community Inclusion Team supports the University Centers for Excellence in Developmental Disabilities (UCEDD) Network in partnership with the Administration for Community Living.

Learn More
|

AUCD Maternal and Child Health Engagement

AUCD’s Maternal and Child Health Engagement supports the Autism CARES Programs, including LEND and DBP Programs.

Learn More
|

AUCD Public Health

AUCD’s Public Health Team works to create health promotion and public health efforts that include people with disabilities.

Learn More
|

AUCD Emerging Leaders Community

AUCD Emerging Leaders are a part of a community that includes trainees, early career professionals, self-advocates, and family members from AUCD member Centers and Programs.

Learn More

Donate

Product

The Impact of Microarray in Diagnosing Pediatric Acute Lymphocytic Leukemia.

Center:

NE-Munroe-Meyer Institute of Genetics & Rehabilitation, UCEDD/LEND

Fiscal Year:

2014

Contact Information:

Kellie Ellerbusch
[email protected]
402-559-4892

Product Description:

Acute lymphocytic leukemia (ALL) is the most common form of childhood cancer representing 23% of cancer diagnoses in children. With current therapeutic regimens, long-term survival can be expected in approximately 80% of cases. Cytogenetics and FISH are the gold standard for defining abnormalities that facilitate treatment stratification. Microarray studies which provide higher resolution and genome wide analyses have identified significant abnormalities that cyto and FISH cannot. To better refine the diagnosis and improve prognosis/risk stratification, we included microarray in our pilot study of newly-diagnosed pediatric ALL patients.

Keyword(s):

Acute lymphocytic leukemia, Micrroarray

Product/Publication Type(s):

Conference presentations and posters presented

Target Audience:

Professionals

Alternative Format:

Electronic (disc, CD, 508 compliant web posting)

To Obtain Copies (URL or Email):

[email protected]

COVID-19 Related Data:

N/A